Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Global Chronic Heart Failure Market 2017-2024: Entresto will be the Main Driver of Growth | ||
By: PR Newswire Association LLC. - 15 Feb 2018 | Back to overview list |
|
DUBLIN, Feb. 15, 2018 /PRNewswire/ -- The "Chronic Heart Failure Market and Forecast Analysis to 2024" report has been added to ResearchAndMarkets.com's offering. Chronic heart failure (CHF) is a serious medical condition in which the heart is unable to adequately fill with and eject blood. CHF can result from functional abnormalities such as ventricular dysfunction or arrhythmias, but structural disorders of the heart muscle or valves are also common causes. While current therapies have helped to improve patient outcomes, CHF still remains a major public health issue and is associated with high mortality rates and a poor prognosis. Market Snapshot
Key Topics Covered:
Treatment: Chronic Heart Failure
Epidemiology: Chronic Heart Failure
Marketed Drugs: Chronic Heart Failure
Pipeline: Chronic Heart Failure
For more information about this report visit https://www.researchandmarkets.com/research/wfzvnf/global_chronic?w=5 Media Contact: Laura Wood, Senior Manager View original content:http://www.prnewswire.com/news-releases/global-chronic-heart-failure-market-2017-2024-entresto-will-be-the-main-driver-of-growth-300599378.html SOURCE Research and Markets |
||
|
||
Copyright 2018 PR Newswire Association LLC. | Back to overview list |